Boston Scientific Corporation

Boston Scientific Corporation announced U.S. Food and Drug Administration (FDA) approval for three products in its Cardiac Rhythm Management business. They are: The CONFIENT(TM) implantable cardioverter defibrillator (ICD), which helps protect patients at risk of sudden cardiac death; The LIVIAN(TM) cardiac resynchronization therapy defibrillator (CRT-D), which provides cardiac resynchronization and defibrillation therapies in one device; An upgraded LATITUDE(R) Patient Management System, with enhanced remote monitoring capabilities. Both the CONFIENT ICD and LIVIAN CRT-D enable physicians to manage their patients wirelessly on the LATITUDE Patient Management System. The LATITUDE system helps physicians impact patient outcomes by notifying them of changes in a patient's clinical status between normally scheduled follow-ups, enabling them to intervene earlier in a patient's care.